Harvard Bioscience Research and Development Expenses 2010-2025 | HBIO

Harvard Bioscience research and development expenses from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
Harvard Bioscience Annual Research and Development Expenses
(Millions of US $)
2024 $10
2023 $12
2022 $12
2021 $11
2020 $9
2019 $11
2018 $11
2017 $6
2016 $5
2015 $6
2014 $5
2013 $4
2012 $4
2011 $4
2010 $5
2009 $4
Harvard Bioscience Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31 $2
2024-12-31 $2
2024-09-30 $3
2024-06-30 $3
2024-03-31 $3
2023-12-31 $3
2023-09-30 $3
2023-06-30 $3
2023-03-31 $3
2022-12-31 $3
2022-09-30 $3
2022-06-30 $3
2022-03-31 $3
2021-12-31 $3
2021-09-30 $3
2021-06-30 $3
2021-03-31 $2
2020-12-31 $2
2020-09-30 $2
2020-06-30 $2
2020-03-31 $2
2019-12-31 $3
2019-09-30 $3
2019-06-30 $3
2019-03-31 $3
2018-12-31 $3
2018-09-30 $3
2018-06-30 $3
2018-03-31 $2
2017-12-31 $2
2017-09-30 $2
2017-06-30 $1
2017-03-31 $1
2016-12-31 $1
2016-09-30 $1
2016-06-30 $2
2016-03-31 $1
2015-12-31 $2
2015-09-30 $1
2015-06-30 $2
2015-03-31 $2
2014-12-31 $2
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31 $1
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $-1
2012-09-30 $2
2012-06-30 $2
2012-03-31 $2
2011-12-31 $0
2011-09-30 $2
2011-06-30 $1
2011-03-31 $1
2010-12-31 $1
2010-09-30 $1
2010-06-30 $1
2010-03-31 $1
2009-12-31 $1
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.015B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.787B 16.25
Kewaunee Scientific (KEQU) United States $0.105B 7.41